Understanding the Dietary Adjustments Following GLP-1 Agonist Treatment: The GLaD Feasibility Study
NCT: NCT07001553 ·
Status: COMPLETED ·
Phase: N/A
· Sponsor: Australian Catholic University
· Started: 2025-05-28
· Est. Completion: 2026-01-07
Official Summary
An observational study of those who have been prescribed a GLP-1 agonist therapy (yet to commence), for either weight or diabetes management, and are willing to complete dietary records and questionnaires of behaviour and psychosocial health.
Study Design
- Study Type: OBSERVATIONAL
- Enrollment: 37 participants
Primary Outcomes
- Feasibility of recruitment (4 months)
Secondary Outcomes
- Energy intake (baseline, 2 weeks, 1 month, 3 months)
- Medication symptomology (baseline, 1 month, 3 months)
- Medication use (baseline, 1 month, 3 months)
Trial Locations
- Australian Catholic University, Fitzroy, Victoria, Australia
More Obesity Trials
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.